期刊
PSYCHOPHARMACOLOGY
卷 239, 期 5, 页码 1251-1261出版社
SPRINGER
DOI: 10.1007/s00213-021-05768-0
关键词
CB1 receptor agonists; Cannabimimetic; Spice; Schizophrenia; Clinical characteristics; Clinical study
资金
- Bund gegen Alkohol und Drogen im Strasenverkehr (B.A.D.S.)
The study aimed to assess the psychotomimetic effects of a moderate dose of JWH-018, revealing that it induces pronounced psychotomimetic symptoms in healthy participants with no history of mental illness, confirming the serious risk SCs pose for public health.
Background Synthetic cannabinoids (SCs) are the largest class of novel psychoactive substances (NPS) and are associated with an increased risk of overdosing and adverse events such as psychosis. JWH-018 is one of the earliest SCs and still widely available in large parts of the world. Controlled studies to assess the safety and behavioural profiles of SCs are extremely scarce. Aim The current study was designed to assess the psychotomimetic effects of a moderate dose of JWH-018. Methods Twenty-four healthy participants (10 males, 14 females) entered a placebo-controlled, double blind, within-subjects trial and inhaled vapour of placebo or 75 mu g/kg bodyweight JWH-018. To ascertain a minimum level of intoxication, a booster dose of JWH-018 was administered on an as-needed basis. The average dose of JWH-018 administered was 5.52 mg. Subjective high, dissociative states (CADSS), psychedelic symptoms (Bowdle), mood (POMS) and cannabis reinforcement (SCRQ) were assessed within a 4.5-h time window after drug administration. Results JWH-018 caused psychedelic effects, such as altered internal and external perception, and dissociative effects, such as amnesia, derealisation and depersonalisation and induced feelings of confusion. Conclusion Overall, these findings suggest that a moderate dose of JWH-018 induces pronounced psychotomimetic symptoms in healthy participants with no history of mental illness, which confirms that SCs pose a serious risk for public health.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据